Search

everythinglearnresearchcommunity

for

Search:↓

Combining irinotecan and cetuximab is effective for some metastatic colorectal cancer patients but often causes manageable skin issues.

Cetuximab can cause unusual hair growth and hair loss.

Methotrexate is a promising and safe treatment for severe alopecia areata, with better results when combined with corticosteroids.

WNT10B is important for body functions and linked to diseases like osteoporosis, obesity, and cancer.

Anticancer drugs like methotrexate and trimetrexate could be effective and safe for treating malaria at low doses.

Tailored treatments for alopecia areata are recommended based on severity and patient needs.

Reducing reactive oxygen species can help treat nerve damage from platinum cancer drugs.

Treat alopecia areata with personalized plans, using corticosteroids for mild cases and Janus Kinase inhibitors for severe cases, while also offering psychological support.

Reporter characteristics affect detection of hair loss from cancer therapy.

Chemotherapy for breast cancer often causes significant and lasting hair loss.

Non-biologic immunosuppressive drugs are crucial for treating autoimmune and chronic inflammatory skin diseases.

Protein Kinase Cε increases skin sensitivity to UV damage and skin cancer risk.

Folic acid helped a calf regrow hair lost due to deficiency.

The new delivery system improves treatment for hair loss by enhancing drug absorption and effectiveness.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

Fusidic acid successfully treated a rare scalp infection with hair regrowth and no recurrence after 6 months.

Folate salts penetrate skin well and improve wound healing, suggesting potential for skin treatments.

Topical folates can penetrate skin and enhance wound healing.

Methotrexate may help stabilize frontal fibrosing alopecia.

Folicrex may help with hair growth and health but lacks clinical evidence.

Finasteride helps hair regrowth in frontal fibrosing alopecia.

FOL-005, a new substance, was found to reduce hair growth without toxicity when injected into skin, suggesting it could be used to treat excessive hair growth.

Some postmenopausal women with frontal fibrosing alopecia stopped losing hair with finasteride treatment, hinting at a possible hormonal cause.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

Finasteride helps treat frontal fibrosing alopecia, improving or stabilizing the condition in many patients.

Riboflavin 5′-phosphate (FMN) shows potential for treating androgen-related conditions but may be limited in treating prostate cancer.

A new peptide, FOL-005, may help treat excessive hair growth by reducing a hair growth promoter, FGF7.

DFMO may help control hair growth and treat cancer.

FOL-005 peptide can reduce human hair growth by lowering FGF7 levels.